Cue Biopharma is trading 5.53% down today at $31.26 as the stock pulls back. - The decline follows a 1-for-30 reverse stock split that took effect on July 23, 2026. - This corporate action often leads to increased price volatility and can be a catalyst for profit-taking after a recent rally. - No other immediate company-specific news has been identified to explain today's move.